Skip to main content

Table 5 Multivariate analysis of the survival of IPSS-R lower-risk subjects with respect to dysplastic mono-nucleated megakaryocytes

From: A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

  HR 95 % CI P value
Age (year)    0.03
 ≥60 1.808 1.058–3.089  
 <60* 1.0   
Gender    0.161
 IPSS-R    0.018
 Very-low 0 0–1.07E266  
 Low 0.463 0.272–0.789  
 Intermediate* 1.0   
Mono-nucleated (%)    <0.01
 ≥30 2.672 1.410–5.064  
 <30* 1.0   
  1. * The reference